Grifols SANASDAQ:GRFS
- LAST PRICE6.6400
- TODAY'S CHANGE (%)0.1200 (1.8405%)
- Bid / Lots6.2500/ 3
- Ask / Lots6.7200/ 1
- Open / Previous Close6.5600 / 6.5200
- Day Range
- 52 Week Range
- Volume436,830
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | GRFS |
|---|---|---|
| 09:32 ET | 8555 | 6.55 |
| 09:34 ET | 3727 | 6.56 |
| 09:36 ET | 3557 | 6.565 |
| 09:38 ET | 10882 | 6.605 |
| 09:39 ET | 7600 | 6.61 |
| 09:41 ET | 2300 | 6.625 |
| 09:43 ET | 8452 | 6.62 |
| 09:45 ET | 4026 | 6.59 |
| 09:48 ET | 8606 | 6.6 |
| 09:50 ET | 1100 | 6.6 |
| 09:52 ET | 460 | 6.6 |
| 09:54 ET | 564 | 6.6 |
| 09:56 ET | 1053 | 6.605 |
| 09:57 ET | 2166 | 6.6482 |
| 09:59 ET | 1654 | 6.63 |
| 10:01 ET | 3609 | 6.6623 |
| 10:03 ET | 1309 | 6.65 |
| 10:06 ET | 9104 | 6.66 |
| 10:08 ET | 17736 | 6.655 |
| 10:10 ET | 2908 | 6.63 |
| 10:12 ET | 4588 | 6.62 |
| 10:14 ET | 14834 | 6.655 |
| 10:15 ET | 865 | 6.66 |
| 10:17 ET | 1518 | 6.667 |
| 10:19 ET | 100 | 6.66 |
| 10:21 ET | 3427 | 6.665 |
| 10:24 ET | 203 | 6.67 |
| 10:26 ET | 1480 | 6.69 |
| 10:28 ET | 2701 | 6.675 |
| 10:30 ET | 3582 | 6.66 |
| 10:32 ET | 3109 | 6.675 |
| 10:33 ET | 10363 | 6.695 |
| 10:35 ET | 638 | 6.695 |
| 10:37 ET | 900 | 6.695 |
| 10:39 ET | 7980 | 6.695 |
| 10:42 ET | 1000 | 6.69 |
| 10:44 ET | 1310 | 6.68 |
| 10:46 ET | 100 | 6.675 |
| 10:48 ET | 421 | 6.68 |
| 10:50 ET | 1500 | 6.685 |
| 10:51 ET | 450 | 6.685 |
| 10:53 ET | 4395 | 6.675 |
| 10:55 ET | 10382 | 6.69 |
| 10:57 ET | 200 | 6.69 |
| 11:00 ET | 114 | 6.7 |
| 11:02 ET | 3154 | 6.6895 |
| 11:04 ET | 5650 | 6.695 |
| 11:06 ET | 2923 | 6.68 |
| 11:08 ET | 800 | 6.67 |
| 11:11 ET | 1094 | 6.66 |
| 11:13 ET | 4400 | 6.665 |
| 11:15 ET | 100 | 6.67 |
| 11:18 ET | 367 | 6.665 |
| 11:20 ET | 2417 | 6.67 |
| 11:22 ET | 1271 | 6.675 |
| 11:24 ET | 1026 | 6.675 |
| 11:26 ET | 2200 | 6.675 |
| 11:27 ET | 2382 | 6.66 |
| 11:29 ET | 3370 | 6.675 |
| 11:31 ET | 213 | 6.6767 |
| 11:33 ET | 105 | 6.6601 |
| 11:36 ET | 903 | 6.665 |
| 11:38 ET | 952 | 6.665 |
| 11:40 ET | 200 | 6.66 |
| 11:47 ET | 743 | 6.66 |
| 11:49 ET | 939 | 6.665 |
| 11:51 ET | 200 | 6.66 |
| 11:54 ET | 100 | 6.665 |
| 11:58 ET | 1386 | 6.66 |
| 12:00 ET | 6248 | 6.645 |
| 12:02 ET | 11320 | 6.645 |
| 12:03 ET | 800 | 6.645 |
| 12:05 ET | 2307 | 6.645 |
| 12:07 ET | 6328 | 6.645 |
| 12:09 ET | 1152 | 6.645 |
| 12:12 ET | 6054 | 6.655 |
| 12:14 ET | 674 | 6.65 |
| 12:16 ET | 2200 | 6.645 |
| 12:18 ET | 7357 | 6.665 |
| 12:20 ET | 1526 | 6.665 |
| 12:21 ET | 400 | 6.665 |
| 12:23 ET | 300 | 6.665 |
| 12:25 ET | 700 | 6.665 |
| 12:27 ET | 400 | 6.665 |
| 12:30 ET | 7002 | 6.675 |
| 12:32 ET | 1600 | 6.675 |
| 12:34 ET | 600 | 6.675 |
| 12:36 ET | 400 | 6.6705 |
| 12:38 ET | 900 | 6.675 |
| 12:39 ET | 1561 | 6.675 |
| 12:41 ET | 10427 | 6.665 |
| 12:43 ET | 400 | 6.665 |
| 12:45 ET | 600 | 6.665 |
| 12:48 ET | 700 | 6.665 |
| 12:50 ET | 9884 | 6.675 |
| 12:52 ET | 4612 | 6.67 |
| 12:54 ET | 11602 | 6.675 |
| 12:56 ET | 9279 | 6.665 |
| 12:57 ET | 27891 | 6.65 |
| 12:59 ET | 26492 | 6.64 |
Today
DJ Grifols Appoints Rahul Srinivasan as Chief Financial Officer, from 2 hours ago by Dow Jones
2 hours ago by Dow Jones
Yesterday
The Schall Law Firm Commences Inquiry Into Allegations Against Grifols SA And Urges Affected Investors To Initiate Communication, from 12:31PM ET on Wednesday Jul 03, 2024 by Dow Jones
12:31PM ET on Wednesday Jul 03, 2024 by Dow Jones
Jul 2, 2024
Probe Into Claims Against Grifols SA Initiated By The Schall Law Firm And Impacted Investors Are Encouraged To Start Contact, from 3:03PM ET on Tuesday Jul 02, 2024 by Dow Jones
3:03PM ET on Tuesday Jul 02, 2024 by Dow Jones
Jul 1, 2024
Grifols' Biotest to achieve USD 1 billion in US sales of Yimmugo(R) over next seven years, from 6:00AM ET on Monday Jul 01, 2024 by Dow Jones
6:00AM ET on Monday Jul 01, 2024 by Dow Jones
Jun 28, 2024
The Schall Law Firm Begins Probe Into Claims Against Grifols SA And Urges Affected Investors To Initiate Contact, from 11:06AM ET on Friday Jun 28, 2024 by Dow Jones
11:06AM ET on Friday Jun 28, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Grifols SA | 5.6B | 21.9x | --- |
ICON PLC | 26.3B | 38.6x | +4.68% |
Charles River Laboratories International Inc | 10.4B | 23.6x | +15.57% |
Incyte Corp | 12.9B | 17.5x | +39.11% |
Fortrea Holdings Inc | 2.1B | -20.8x | --- |
Biontech SE | 19.0B | 155.7x | --- |
Company Information
Grifols SA is a Spain-based global specialty pharmaceutical company developing, manufacturing and distributing a broad range of biological medicines based on plasma derived proteins. It organizes its business into five divisions: Bioscience, Diagnostic, Hospital, Bio Supplies and Others. Bioscience includes manufacturing activities of plasma derivatives for therapeutic use and the sale and distribution of end products. Diagnostic focuses on researching, developing, manufacturing and marketing in vitro diagnostics products, such as analytical instruments, reagents and software, among others, for laboratories. Hospital offers technology and services for hospitals, clinics and specialized centers for the manufacture of medicines, as well as physiological saline solution, enteral nutritional fluids and medical devices for interventional therapy. Bio Supplies provides, mostly, biological products for non-therapeutic use. Others provides manufacturing services to third party companies.
Contact Information
- Headquarters
- C/ Jesus y Maria, 6BARCELONA, BAR, Spain 08022
- Phone
- ---
- Fax
- ---
Executives
- Chairman, Executive Director
- Thomas Glanzmann
- Chief Executive Officer, Executive Director
- Jose Ignacio Abia
- Chief Financial Officer
- Alfredo Arroyo Guerra
- President - Plasma Procurement
- Jordi Balsells Valls
- President - Bio Supplies
- Alberto Grifols Roura
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $5.6B |
|---|---|
Revenue (TTM) | $7.2B |
Shares Outstanding | 687.6M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 0.49 |
EPS | $0.30 |
Book Value | $9.26 |
P/E Ratio | 21.9x |
Price/Sales (TTM) | 0.8 |
Price/Cash Flow (TTM) | 7.3x |
Operating Margin | 14.31% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
